Abstract: A layout of a semiconductor memory device includes a substrate and a ternary content addressable memory (TCAM). The TCAM is disposed on the substrate and includes a plurality of TCAM bit cells, where at least two of the TCAM bit cells are mirror-symmetrical along an axis of symmetry, and each of the TCAM bit cells includes two storage units electrically connected to two word lines respectively, and a logic circuit electrically connected to the storage units. The logic circuit includes two first reading transistors, and two second reading transistors, where each of the second reading transistors includes a gate and source and drain regions, the source and drain regions of the second reading transistors are electrically connected to two matching lines and the first reading transistors, respectively, where the word lines are disposed parallel to and between the matching lines.

Abstract: A video processing method for detecting location(s), pixels, and skeleton(s) of one or more objects and an associated video processing circuit are provided. The video processing method may include: utilizing a backbone network in a predetermined model of a single deep learning network to receive and convert input image data having the object(s) into at least one feature map; and utilizing at least one instance head and a pixel head in the predetermined model of the single deep learning network to receive and convert the aforementioned at least one feature map into one or more object detection results, one or more instance segmentation results and one or more pose estimation results of the object(s).

Abstract: The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material, in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1, CS2, CS3, CS4 and CS5.

Abstract: A method for unlocking an electronic device, a first image in a first area and a second image in a second area selected on a touch panel of the electronic device are received. The method combines the first image and the second image to obtain a selected combination image, and unlocks the electronic device upon the condition that the selected combination image is stored in a storage unit of the electronic device.

Abstract: The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material, in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1, CS2, CS3, CS4 and CS5.

Abstract: An electronic device acquires first character data of a hand, and displays an outline diagram of the hand on a touch screen display according to the first character data, in response to a user placing his/her hand on the touch screen display. The electronic device sets associations between editing tools and fingers of the hand in the outline diagram. Then, the electronic device detects second character data of a finger of the hand in response to the user touching the touch screen display with the finger, and compares the second character data with the first character data, to determine which editing tool is associated with that finger according to the set associations, and replaces a present available editing tool on the touch screen display with the determined editing tool.

Abstract: A method for unlocking an electronic device, a first image in a first area and a second image in a second area selected on a touch panel of the electronic device are received. The method combines the first image and the second image to obtain a selected combination image, and unlocks the electronic device upon the condition that the selected combination image is stored in a storage unit of the electronic device.

Abstract: In a method for detecting compatibility of files of an electronic device, the method obtains a size and a format of an original file in response to moving the original file from an original storage area to a destination, and determines whether the original file and the destination are compatible with each other. If the original file and the destination are compatible with each other, the method receives the original file to the destination. If the original file and the destination are incompatible with each other, the method displays a prompt that the original file and the destination are incompatible on a display device of the electronic.

Abstract: In an agenda management method of an electronic device, one or more items of an agenda are set, and a time period and an alarm time is set for each of the items. A user interface is displayed for the setting of the agenda, and an analog clock is displayed on the user interface. An area on the analog clock is determined for each item to show the item according to the time when it will happen, and a first color is displayed in each determined area. A user of the electronic device is notified when a prior warning time of any item is reached, and a second color is displayed in the determined area of the item. A third color is displayed in the determined area of the item when the starting time of the item has been reached.

Abstract: New anhydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided.

Abstract: In a method for managing files using an electronic device, the method determines whether a touch operation on a touchscreen corresponds to an icon of a confirmed file. If the touch operation corresponds to the icon of the confirmed file, touch operations of dragging the icon of the confirmed file to an icon of a target folder on the touchscreen are detected. The icon of the confirmed file is controlled to move towards the icon of the target folder and the target folder is confirmed. The confirmed file is stored into the target folder when the target folder is confirmed.

Abstract: The present application provides several crystalline forms of gemcitabine base and methods of making the same.

Abstract: Crystalline granisetron hydrochloride characterized by a powder x-ray diffraction pattern with peaks at about 14.3, 20.4, and 23.0±0.2 degrees two-theta and process of making the same are disclosed.

Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.

Abstract: A crystalline polymorph of 7-ethyl-10-hydroxycamptothecin exhibiting an X-ray diffraction pattern having peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degree.

Abstract: Novel crystalline forms of topotecan hydrochloride and processes of making the same are disclosed.

Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.

Abstract: A method of enhancing an immune response to an antigen is provided. The method involves augmenting the level of a TAP molecule in a target cell bearing the antigen. Preferably, the TAP molecules enhanced by administering a nucleic acid sequence encoding a TAP-1 and/or TAP-2 molecule. The method is useful in treating infectious diseases and cancer.

Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.

Abstract: A vaccine composition for combating Pox viridae viral infections in living organisms such as mammals (including humans) comprises TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells and hence their immunogenicity. The composition may be used alone or, preferably, as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox.